Bevacizumab
#
Find similar titles
- (rev. 1)
- Hyungyong Kim
Structured data
- Drug Class
- Angiogenesis inhibitor
- URL
- https://en.wikipedia.org/wiki/Bevacizumab
Bevacizumab, sold under the trade name Avastin, is an Angiogenesis inhibitor, a drug that slows the growth of new blood vessels. Bevacizumab is a recombinant humanized Monoclonal antibody that blocks Angiogenesis by inhibiting VEGF. (https://en.wikipedia.org/wiki/Bevacizumab)
Targets
Incoming Links #
Related Medical Scholarly Articles (MedicalScholarlyArticle 0) #
Related Articles (Article 1) #
Suggested Pages #
- 0.125 Next generation sequencing of triple negative breast cancer to find predictors for chemotherapy response
- 0.125 BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells
- 0.038 CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
- 0.038 Exome sequencing
- 0.025 Ependymoma
- 0.025 May 2
- 0.025 Crizotinib
- 0.025 p16
- 0.025 Oncotarget
- 0.025 TP53
- More suggestions...